hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-05-03专访还原全球首只新冠确诊老虎检测每一次:全麻,虎口取拭
- 2022-04-2520121024新闻联播健康之路:王伟钢讲鲤鱼的营养价值
- 2022-04-25一文把持癫痫用药宝典
- 2022-04-21隐源性癫痫致死率翻倍
- 2022-04-20隐源性癫痫死亡率总和
- 2022-04-13【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 癫痫患者停药问题解决了吗?最新的预测模型已经发布!
- 癫痫患者手术评估新型工具
- 北京哪家癫痫医院排名好,成本低
- FDA批准Aptiom用于治疗患者癫痫发作
- 癫痫治疗障碍仍难以克服
- 预测癫痫患者再入院风险
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 癫痫患者应多喝牛奶,饮食疗法公开
- 羊角病能生孩子吗?
- 2015第31届国际癫痫大会(IEC)
- 【用药情报站】临床应用应听取各种药种药物禁忌证?
- 2016AAN:神经专家发表了有前途的专业见解
- 睡觉时突然抽搐 新生儿睡觉抽搐怎么办?
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 心理百科:春节期间小心疾病
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 抗癫痫药物预防新发癫痫:任重而道远
- 月经性癫痫患者妊娠期癫痫控制更好
- 38癫痫患者年病史上的感谢信 道出了浓浓的医患情况
- 癫痫的治疗方法 中医拔罐治疗癫痫的小方法(2)
- DCR: 慢性肾病对局部晚期直肠癌患者接受新辅助放化疗的预后影响
- 综述:癫痫持续状态诊治最新进展
- UCB的Vimpat癫痫新适应症在美国获批
- 2013国际抗癫痫联合会抗癫痫药用指南
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 癫痫猝死:凶手是谁?
- 最新癫痫病化疗方法有何办法医治
- 未婚癫痫病的怎么治疗
- 治疗癫痫病比较好的作法有哪些
- 药剂难治性癫痫患者的神经调控治疗
- 癫痫病的初期有什么症状
- 中老年癫痫病患者发作的病因主要是有哪些
- 美国神经病学协会的新指南借此医生为HIV患者更好地选择癫痫药物
- 先天性癫痫病有什么征状
- 癫痫病发作时有哪些疼痛
- 昭和年间癫痫病哪里好效果好吗
- 答疑癫痫100不知第四期:哪些后天因素最容易造成癫痫?
- 疗法癫痫病比较好的方法是什么
- 千万别漠视婴儿癫痫病症状